{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T11:12:20Z","timestamp":1795173140776,"version":"4.10.3"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The purpose of this study was to perform a systematic review and meta-analysis to determine the diagnostic performance of current noninvasive imaging modalities for assessment of axillary response after neoadjuvant systemic therapy (NST) in clinically node-positive breast cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary of Background Data:<\/jats:title>\n                    <jats:p>NST can lead to downstaging of axillary lymph node disease. Imaging can potentially provide information about the axillary response to NST and, consequently, tailor the surgical management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>PubMed and Embase were searched for studies that compared noninvasive imaging after NST with axillary surgery outcome to identify axillary response in patients with initial pathologically proven axillary lymph node metastasis. Two reviewers independently screened the studies and extracted the data. A meta-analysis was performed by computing the pooled sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Thirteen studies describing 2380 patients were included for final analysis. Of these patients, 1322 had undergone axillary ultrasound, 849 breast MRI, and 209 whole-body\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET-CT. The overall axillary pathologic complete response rate was 39.5% (941\/2380). For axillary ultrasound, the pooled sensitivity, specificity, PPV, and NPV were 65%, 69%, 77%, 50%, respectively. For breast MRI, the pooled sensitivity, specificity, PPV, and NPV were 60%, 76%, 78%, 58%, respectively. For whole-body\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET-CT, the pooled sensitivity, specificity, PPV, and NPV were 38%, 86%, 78%, 49%, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The diagnostic performance of current noninvasive imaging modalities is limited to accurately assess axillary response after NST in clinically node-positive breast cancer patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/sla.0000000000004356","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T22:02:17Z","timestamp":1605736937000},"page":"694-700","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":99,"title":["Diagnostic Performance of Noninvasive Imaging for Assessment of Axillary Response After Neoadjuvant Systemic Therapy in Clinically Node-positive Breast Cancer"],"prefix":"10.1097","volume":"273","author":[{"given":"Sanaz","family":"Samiei","sequence":"first","affiliation":[{"name":"Department of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands"},{"name":"Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands"},{"name":"GROW \u2013 School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis M.","family":"de Mooij","sequence":"additional","affiliation":[{"name":"Department of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands"},{"name":"GROW \u2013 School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc B. I.","family":"Lobbes","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands"},{"name":"GROW \u2013 School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands"},{"name":"Department of Medical Imaging, Zuyderland Medical Center, Sittard-Geleen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristien B. M. I.","family":"Keymeulen","sequence":"additional","affiliation":[{"name":"Department of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiemo J. A.","family":"van Nijnatten","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein L.","family":"Smidt","sequence":"additional","affiliation":[{"name":"Department of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands"},{"name":"GROW \u2013 School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,11,16]]},"reference":[{"key":"R1-20250423","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/jamaoncol.2015.4935","article-title":"Ten-year outcomes of patients with breast cancer with cytologically confirmed axillary lymph node metastases and pathologic complete response after primary systemic chemotherapy","volume":"2","author":"Mougalian","year":"2016","journal-title":"JAMA Oncol"},{"key":"R2-20250423","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/cncr.25152","article-title":"Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer","volume":"116","author":"Dominici","year":"2010","journal-title":"Cancer"},{"key":"R3-20250423","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol"},{"key":"R4-20250423","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","article-title":"Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients the MARI procedure","volume":"261","author":"Donker","year":"2015","journal-title":"Ann Surg"},{"key":"R5-20250423","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.clbc.2017.04.006","article-title":"A novel less-invasive approach for axillary staging after neoadjuvant chemotherapy in patients with axillary node-positive breast cancer by combining radioactive iodine seed localization in the axilla with the sentinel node procedure (RISAS): a Dutch prospective multicenter validation study","volume":"17","author":"van Nijnatten","year":"2017","journal-title":"Clin Breast Cancer"},{"key":"R6-20250423","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ejso.2015.07.020","article-title":"The diagnostic performance of sentinel lymph node biopsy in pathologically confirmed node positive breast cancer patients after neoadjuvant systemic therapy: a systematic review and meta-analysis","volume":"41","author":"van Nijnatten","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"R7-20250423","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ejso.2016.03.023","article-title":"Management of the axilla after neoadjuvant chemotherapy for clinically node positive breast cancer: a nationwide survey study in The Netherlands","volume":"42","author":"Vugts","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"R8-20250423","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1245\/s10434-017-5958-4","article-title":"Use of sentinel lymph node dissection after neoadjuvant chemotherapy in patients with node-positive breast cancer at diagnosis: practice patterns of American Society of Breast Surgeons Members","volume":"24","author":"Caudle","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"R9-20250423","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1093\/annonc\/mdz189","article-title":"Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann Oncol"},{"key":"R10-20250423","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.2017.19163","article-title":"Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement","volume":"319","author":"McInnes","year":"2018","journal-title":"JAMA"},{"key":"R11-20250423","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"R12-20250423","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/2049-3258-72-39","article-title":"Metaprop: a Stata command to perform meta-analysis of binomial data","volume":"72","author":"Nyaga","year":"2014","journal-title":"Arch Public Health"},{"key":"R13-20250423","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"R15-20250423","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0019-509X.12339","article-title":"Complete axillary conversion after neoadjuvant chemotherapy in locally advanced breast cancer: a step towards conserving axilla?","volume":"41","author":"Arimappamagan","year":"2004","journal-title":"Indian J Cancer"},{"key":"R16-20250423","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1200\/JCO.2014.57.8401","article-title":"Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the American College of Surgeons Oncology Group Z1071 Trial (Alliance)","volume":"33","author":"Boughey","year":"2015","journal-title":"J Clin Oncol"},{"key":"R17-20250423","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1177\/0284185117690421","article-title":"Diagnostic performance of breast ultrasonography and MRI in the prediction of lymph node status after neoadjuvant chemotherapy for breast cancer","volume":"58","author":"Ha","year":"2017","journal-title":"Acta Radiol"},{"key":"R18-20250423","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1245\/s10434-013-3118-z","article-title":"Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer","volume":"20","author":"Hieken","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"(Supplement 1)","key":"R19-20250423","first-page":"S8","article-title":"Axillary lymph node ultrasound following neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: results from the SN FNAC study","volume":"26","author":"Morency","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"R20-20250423","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/tbj.13488","article-title":"Sonographic features of benign and malignant axillary nodes post-neoadjuvant chemotherapy","volume":"26","author":"Shin","year":"2020","journal-title":"Breast J"},{"key":"R21-20250423","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1007\/s00330-016-4235-4","article-title":"Preoperative axillary lymph node evaluation in breast cancer patients by breast magnetic resonance imaging (MRI): can breast MRI exclude advanced nodal disease?","volume":"26","author":"Hyun","year":"2016","journal-title":"Eur Radiol"},{"key":"R22-20250423","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1245\/s10434-019-07867-x","article-title":"Is clinical exam of the axilla sufficient to select node-positive patients who downstage after NAC for SLNB? A comparison of the accuracy of clinical exam versus MRI","volume":"26","author":"Moo","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"R23-20250423","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jamcollsurg.2017.08.027","article-title":"MRI and prediction of pathologic complete response in the breast and axilla after neoadjuvant chemotherapy for breast cancer","volume":"225","author":"Weber","year":"2017","journal-title":"J Am Coll Surg"},{"key":"R24-20250423","doi-asserted-by":"crossref","first-page":"20150143","DOI":"10.1259\/bjr.20150143","article-title":"Evaluation of lymph node status after neoadjuvant chemotherapy in breast cancer patients: comparison of diagnostic performance of ultrasound, MRI and (1)(8)F-FDG PET\/CT","volume":"88","author":"You","year":"2015","journal-title":"Br J Radiol"},{"key":"R25-20250423","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1245\/s10434-010-0934-2","article-title":"Can breast MRI predict axillary lymph node metastasis in women undergoing neoadjuvant chemotherapy","volume":"17","author":"Javid","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R26-20250423","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1097\/RLU.0000000000001191","article-title":"Prognostic role of early and end-of-neoadjuvant treatment 18F-FDG PET\/CT in patients with breast cancer","volume":"41","author":"Vicente","year":"2016","journal-title":"Clin Nucl Med"},{"key":"R27-20250423","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1007\/s00330-015-3807-z","article-title":"Breast MRI: EUSOBI recommendations for women's information","volume":"25","author":"Mann","year":"2015","journal-title":"Eur Radiol"},{"key":"R28-20250423","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.ejrad.2016.10.030","article-title":"Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients","volume":"85","author":"van Nijnatten","year":"2016","journal-title":"Eur J Radiol"},{"key":"R29-20250423","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta15040","article-title":"Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation","volume":"15","author":"Cooper","year":"2011","journal-title":"Health Technol Assess"},{"key":"R30-20250423","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1245\/s10434-013-2902-0","article-title":"Early assessment of axillary response with (1)(8)F-FDG PET\/CT during neoadjuvant chemotherapy in stage II-III breast cancer: implications for surgical management of the axilla","volume":"20","author":"Koolen","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"R31-20250423","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00259-010-1640-9","article-title":"Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer","volume":"38","author":"Groheux","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R32-20250423","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1148\/radiol.2015141638","article-title":"Early metabolic response to neoadjuvant treatment: FDG PET\/CT criteria according to breast cancer subtype","volume":"277","author":"Groheux","year":"2015","journal-title":"Radiology"},{"key":"R33-20250423","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00259-015-3070-1","article-title":"Association between (1)(8)F-FDG uptake and molecular subtype of breast cancer","volume":"42","author":"Kitajima","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R34-20250423","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41568-018-0016-5","article-title":"Artificial intelligence in radiology","volume":"18","author":"Hosny","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"R35-20250423","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/SLA.0000000000003075","article-title":"Diagnostic accuracy of different surgical procedures for axillary staging after neoadjuvant systemic therapy in node-positive breast cancer: a systematic review and meta-analysis","volume":"269","author":"Simons","year":"2019","journal-title":"Ann Surg"},{"key":"R36-20250423","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1245\/s10434-017-6270-z","article-title":"Intraoperative ultrasound-guided excision of axillary clip in patients with node-positive breast cancer treated with neoadjuvant therapy (ILINA Trial): a new tool to guide the excision of the clipped node after neoadjuvant treatment","volume":"25","author":"Siso","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"R37-20250423","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10549-017-4157-0","article-title":"Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases","volume":"163","author":"van Nijnatten","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"R38-20250423","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1245\/s10434-019-07517-2","article-title":"Prognostic significance of residual axillary nodal micrometastases and isolated tumor cells after neoadjuvant chemotherapy for breast cancer","volume":"26","author":"Wong","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"R39-20250423","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/cncr.10741","article-title":"Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18","volume":"95","author":"Fisher","year":"2002","journal-title":"Cancer"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SLA.0000000000004356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T18:03:00Z","timestamp":1745431380000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SLA.0000000000004356"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2020,11,16]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0000000000004356","relation":{},"ISSN":["0003-4932","1528-1140"],"issn-type":[{"value":"0003-4932","type":"print"},{"value":"1528-1140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,16]]}}}